title: [Update on pancreatic transplantation].
abstract: Pancreas transplantation significantly improves the quality of life as well as the survival of the diabetic patient. It is also associated with stabilization and reversal of secondary diabetic complications. Improvements in organ preservation, surgical techniques and immunosuppression have achieved one-year graft survival of more than 90% for combined kidney-pancreas transplant and 80% for isolated pancreas transplantation. Recipient evaluation must weigh the benefits of the procedure with the risk associated with surgery and chronic immunosuppression. Combined kidney-pancreas transplantation appears today as the best treatment for the diabetic patient with end stage renal disease. Isolated pancreas transplantation is reserved to non-uremic patients with severe diabetic complications or with brittle glycaemic control and severe impairment of quality of life.
authors.forename: A
authors.initials: A
authors.lastname: De Roover
authors.forename: O
authors.initials: O
authors.lastname: Detry
authors.forename: E
authors.initials: E
authors.lastname: Hamoir
authors.forename: T
authors.initials: T
authors.lastname: Defechereux
authors.forename: M A
authors.initials: MA
authors.lastname: Beaujean
authors.forename: P
authors.initials: P
authors.lastname: Bonnet
authors.forename: P
authors.initials: P
authors.lastname: Honoré
authors.forename: M
authors.initials: M
authors.lastname: Meurisse
authors.forename: N
authors.initials: N
authors.lastname: Jacquet
mesh_terms: D006801:Humans; D007165:Immunosuppression Therapy; D016035:Pancreas Transplantation / Q000009:adverse effects / Q000379:methods; D011183:Postoperative Complications / Q000453:epidemiology; D014019:Tissue Donors; D020858:Tissue and Organ Harvesting